Endothelial NO/cGMP/VASP Signaling Attenuates Kupffer Cell Activation and Hepatic Insulin Resistance Induced by High-Fat Feeding
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Proinflammatory activation of Kupffer cells is implicated in the effect of high-fat feeding to cause liver insulin resistance. We sought to determine whether reduced endothelial nitric oxide (NO) signaling contributes to the effect of high-fat feeding to increase hepatic inflammatory signaling and if so, whether this effect 1) involves activation of Kupffer cells and 2) is ameliorated by increased NO signaling. RESEARCH DESIGN AND METHODS: Effect of NO/cGMP signaling on hepatic inflammation and on isolated Kupffer cells was examined in C57BL/6 mice, eNos−/− mice, and Vasp−/− mice fed a low-fat or high-fat diet. RESULTS: We show that high-fat feeding induces proinflammatory activation of Kupffer cells in wild-type mice coincident with reduced liver endothelial nitric oxide synthase activity and NO content while, conversely, enhancement of signaling downstream of endogenous NO by phosphodiesterase-5 inhibition protects against high fat–induced inflammation in Kupffer cells. Furthermore, proinflammatory activation of Kupffer cells is evident in eNos−/− mice even on a low-fat diet. Targeted deletion of vasodilator-stimulated phosphoprotein (VASP), a key downstream target of endothelially derived NO, similarly predisposes to hepatic and Kupffer cell inflammation and abrogates the protective effect of NO signaling in both macrophages and hepatocytes studied in a cell culture model. CONCLUSIONS: These results collectively imply a physiological role for endothelial NO to limit obesity-associated inflammation and insulin resistance in hepatocytes and support a model in which Kupffer cell activation during high-fat feeding is dependent on reduced NO signaling. Our findings also identify the NO/VASP pathway as a novel potential target for the treatment of obesity-associated liver insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In health, LSECs regulate anti-inflammatory and antifibrotic signalling by preventing KC and HSC activation via nitric oxide, cGMP and VASP (vasodilator stimulated phosphoprotein).138”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733 · cited 2×
“Growing evidence suggests that inflammatory signaling pathways mediate insulin resistance induced by nutrient excess in both cultured hepatocytes and in hepatic tissue in vivo (2,4,7,20).”
BackgroundKanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682 · cited 1×
“Hepatic triglyceride content was measured in liver lysates as previously described (18).”
MethodIKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Insulin and insulin resistance:
Sowers, J. R., & Frohlich, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00128-7 · Cited by 1,518
Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Red Eagle, A., Vats, D., Morel, C. R., Goforth, M. H., Subramanian, V., Mukundan, L., Ferrante, A. W., & Chawla, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.003 · Cited by 847 · cited 2×
“Because Kupffer cells play an important role in the development of hepatic insulin resistance during high-fat feeding (2,20), we next sought to investigate the time course of Kupffer cell activation during high-fat feeding in normal mice using a validated Kupffer cell isolation method (3).”
MethodStructural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review
Braet, F., & Wisse, E. (2002) · Comparative Hepatology · doi:10.1186/1476-5926-1-1 · Cited by 753 · cited 1×
“The liver is a highly vascularized tissue receiving 20% of cardiac output, and hepatic sinusoidal endothelial cells make up 50% of nonparenchymal cells of the liver (8,9).”
BackgroundFundamentals of Endothelial Function for the Clinical Cardiologist
Verma, S., & Anderson, T. J. (2002) · Circulation · doi:10.1161/hc0502.104540 · Cited by 602
Toll-Like Receptor-4 Mediates Vascular Inflammation and Insulin Resistance in Diet-Induced Obesity
Kim, F., Pham, M., Luttrell, I., Bannerman, D. D., Tupper, J., Thaler, J., Hawn, T. R., Raines, E. W., & Schwartz, M. W. (2007) · Circulation Research · doi:10.1161/circresaha.106.142851 · Cited by 584 · cited 3×
“During the final 2 weeks of the highfat feeding protocol, mice on each diet received daily oral administration of either vehicle or the phosphodiesterase-5 (PDE-5) inhibitor sildenafil at a dose (30 mg/kg per day) that did not affect weight gain on either diet compared with the vehicle control group (15).”
MethodInfluentialSelf-citationDuplain, H., Burcelin, R., Sartori, C., Cook, S., Egli, M., Lepori, M., Vollenweider, P., Pedrazzini, T., Nicod, P., Thorens, B., et al. (2001) · Circulation · doi:10.1161/01.cir.104.3.342 · Cited by 533 · cited 1×
“Previous investigators have demonstrated that deletion of eNOS results in increased systemic insulin resistance (21,27).”
BackgroundHuang, W., Metlakunta, A., Dedousis, N., Zhang, P., Sipula, I., Dube, J. J., Scott, D. K., & O'Doherty, R. M. (2010) · Diabetes · doi:10.2337/db09-0016 · Cited by 520 · cited 1×
“Depletion of Kupffer cells using gadolinium chloride attenuated the development of hepatic steatosis and hepatic insulin resistance, suggesting an important early role for Kupffer cells in diet-induced alterations in hepatic insulin resistance (1).”
BackgroundKim, F., Pham, M., Maloney, E., Rizzo, N. O., Morton, G. J., Wisse, B. E., Kirk, E. A., Chait, A., & Schwartz, M. W. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.169722 · Cited by 364 · cited 12×
“Together, these results provide direct evidence in support of the hypothesis that vascular NO/cGMP/VASP signaling plays a physiological role to protect against hepatic inflammation induced during DIO.”
BackgroundMethodInfluentialSelf-citationShah, V, Haddad, F. G., Garcia-Cardena, G., Frangos, J. A., Mennone, A., Groszmann, R. J., & Sessa, W. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119842 · Cited by 350 · cited 1×
“Sinusoidal endothelial cells regulate vascular resistance in the liver through flow-mediated NO production (10) and are also able to scavenge and eliminate soluble waste macromolecules from portal venous blood.”
BackgroundFree Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKKβ
Kim, F., Tysseling, K. A., Rice, J., Pham, M., Haji, L., Gallis, B. M., Baas, A. S., Paramsothy, P., Giachelli, C. M., Corson, M. A., et al. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160549.60980.a8 · Cited by 307
Self-citationShankar, R. R., Wu, Y., Shen, H. Q., Zhu, J. S., & Baron, A. D. (2000) · Diabetes · doi:10.2337/diabetes.49.5.684 · Cited by 296 · cited 2×
“Previous investigators have demonstrated that deletion of eNOS results in increased systemic insulin resistance (21,27).”
BackgroundMechanisms of macrophage activation in obesity-induced insulin resistance
Odegaard, J. I., & Chawla, A. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0976 · Cited by 256
Liu, V. W. T., & Huang, P. L. (2008) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.06.024 · Cited by 251 · cited 1×
“Among early responses observed in association with obesity-induced insulin resistance is a reduction in vascular content of NO, an effect that predisposes to increased endothelial inflammation, thrombosis, and vasoconstriction (5,6).”
BackgroundAyala, J. E., Bracy, D. P., Julien, B. M., Rottman, J. N., Fueger, P. T., & Wasserman, D. H. (2007) · Diabetes · doi:10.2337/db06-0883 · Cited by 237 · cited 2×
“Sildenafil improves insulin sensitivity during high-fat feeding (30), and our data demonstrate improvements in hepatatic steatosis and Kupffer cell inflammation.”
BackgroundRecent advances in nonalcoholic fatty liver disease
Cheung, O., & Sanyal, A. J. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283294a18 · Cited by 219 · cited 1×
“In conjunction with sinusoidal endothelial cells, Kupffer cells situated on the luminal side of the endothelium contribute to this scavenging function as well as to host immunity and immune tolerance (8,11).”
BackgroundLiver architecture, cell function, and disease
Ishibashi, H., Nakamura, M., Komori, A., Migita, K., & Shimoda, S. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0155-6 · Cited by 191 · cited 2×
“In conjunction with sinusoidal endothelial cells, Kupffer cells situated on the luminal side of the endothelium contribute to this scavenging function as well as to host immunity and immune tolerance (8,11).”
BackgroundGRUMBACH, I., CHEN, W., MERTENS, S., & HARRISON, D. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.06.012 · Cited by 181 · cited 1×
“Although endothelial NO exerts antiinflammatory effects in endothelial cells and vascular smooth muscle cells (12), whether it regulates Kupffer cell activation has yet to be tested directly.”
BackgroundRecent advances in nonalcoholic fatty liver disease
Cheung, O., & Sanyal, A. J. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328337b0c4 · Cited by 139
Aversa, A., Vitale, C., Volterrani, M., Fabbri, A., Spera, G., Fini, M., & Rosano, G. M. C. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02298.x · Cited by 132 · cited 1×
“A link between cGMP signaling and insulin action was identified in a recent study in which 12-week treatment with sildenafil improved energy balance and insulin sensitivity in mice fed a high-fat diet (30), and this drug also ameliorates diabetes-induced endothelial dysfunction in both a rat model and in humans (31,32…”
BackgroundBlume, C., Benz, P. M., Walter, U., Ha, J., Kemp, B. E., & Renné, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608866200 · Cited by 126 · cited 1×
“In rodent models of diabetes, PKG and VASP signaling are both reduced in vascular tissues (28) resulting in actin cytoskeleton rearrangements (29), but whether VASP signaling mediates inhibitory effects of NO/PKG on NF-kB signaling has not previously been investigated.”
BackgroundAskari, B., Kanter, J. E., Sherrid, A. M., Golej, D. L., Bender, A. T., Liu, J., Hsueh, W. A., Beavo, J. A., Coleman, R. A., & Bornfeldt, K. E. (2007) · Diabetes · doi:10.2337/db06-0267 · Cited by 98
Rizzo, N. O., Maloney, E., Pham, M., Luttrell, I., Wessells, H., Tateya, S., Daum, G., Handa, P., Schwartz, M. W., & Kim, F. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.199893 · Cited by 98 · cited 1×
“In vitro studies suggest that increased cGMP (using 8Br-cGMP) reduces NF-kB signaling in both hepatocytes and macrophage, and previous studies have demonstrated an inhibitory effect of increased cGMP in endothelial cells (33).”
BackgroundSelf-citationChen, L., Daum, G., Chitaley, K., Coats, S. A., Bowen‐Pope, D. F., Eigenthaler, M., Thumati, N. R., Walter, U., & Clowes, A. W. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000134705.39654.53 · Cited by 93 · cited 3×
“permeability and may underlie growth inhibitory effects of NO on smooth muscle cells (14), its role in the anti-inflammatory action of NO/cGMP/PKG signaling remains unexplored.”
BackgroundInfluentialSelf-citationGenetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury
Duranski, M. R., Elrod, J. W., Calvert, J. W., Bryan, N. S., Feelisch, M., & Lefer, D. J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01173.2005 · Cited by 88 · cited 1×
“In support of this model, both NO donor administration and eNOS overexpression are protective against liver injury in animal models of hepatoxicity (23,24).”
BackgroundMartinelli, R., Gegg, M., Longbottom, R., Adamson, P., Turowski, P., & Greenwood, J. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-06-0636 · Cited by 82
Relaxing the actin cytoskeleton for adhesion and movement with Ena/VASP
Trichet, L., Sykes, C., & Plastino, J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200710168 · Cited by 76 · cited 1×
“Among downstream targets of PKG is vasodilator-stimulated phosphoprotein (VASP), a protein implicated in the control of cytoskeletal dynamics and cell migration (13).”
BackgroundSchäfer, A., Fraccarollo, D., Pförtsch, S., Flierl, U., Vogt, C., Pfrang, J., Kobsar, A., Renné, T., Eigenthaler, M., Ertl, G., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707459 · Cited by 73 · cited 1×
“A link between cGMP signaling and insulin action was identified in a recent study in which 12-week treatment with sildenafil improved energy balance and insulin sensitivity in mice fed a high-fat diet (30), and this drug also ameliorates diabetes-induced endothelial dysfunction in both a rat model and in humans (31,32…”
BackgroundRusso, I., Del Mese, P., Doronzo, G., Mattiello, L., Viretto, M., Bosia, A., Anfossi, G., & Trovati, M. (2008) · Endocrinology · doi:10.1210/en.2007-0920 · Cited by 48 · cited 1×
“In rodent models of diabetes, PKG and VASP signaling are both reduced in vascular tissues (28) resulting in actin cytoskeleton rearrangements (29), but whether VASP signaling mediates inhibitory effects of NO/PKG on NF-kB signaling has not previously been investigated.”
BackgroundGiordano, D., Magaletti, D. M., & Clark, E. A. (2005) · Blood · doi:10.1182/blood-2005-07-2901 · Cited by 44 · cited 1×
“Endothelial NO actively regulates a key and early immune response implicated in atherogenesis by regulating macrophage and lymphocyte capture and vessel wall migration via adhesion molecules (25,26).”
BackgroundLiu, J., & Waalkes, M. P. (2004) · Toxicology · doi:10.1016/j.tox.2004.11.017 · Cited by 41 · cited 1×
“In the context of ischemia reperfusion or exposure to liver toxins, decreased production of NO from eNOS has been linked to liver pathology via dysregulation of blood flow and oxygen delivery (22)—effects that may arise in part from NF-kB–dependent inflammation.”
BackgroundEPR quantification of vascular nitric oxide production in genetically modified mouse models
Khoo, J. P., Alp, N. J., Bendall, J. K., Kawashima, S., Yokoyama, M., Zhang, Y. H., Casadei, B., & Channon, K. M. (2004) · Nitric Oxide · doi:10.1016/j.niox.2004.04.003 · Cited by 33 · cited 1×
“content was measured by using electron spin resonance spectroscopy technique as previously described (7,17).”
MethodRivera-Chávez, F. A., Toledo-Pereyra, L. H., Dean, R. E., Crouch, L. D., & Ward, P. A. (2001) · Journal of Investigative Surgery · doi:10.1080/089419301753170048 · Cited by 30 · cited 1×
“In support of this model, both NO donor administration and eNOS overexpression are protective against liver injury in animal models of hepatoxicity (23,24).”
Background
Cited by
Dixon, L. J., Barnes, M., Tang, H., Pritchard, M. T., & Nagy, L. E. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120026 · Cited by 628
“For example, recent studies have found that high-fat diets increase Kupffer cell activation in a time-dependent mechanism, leading to increased expression of inflammatory cytokines and iNOS expression, due, at least in part, to reduced endothelial NO signalling in the liver (136).”
Redox control of inflammation in macrophages
Brüne, B., Dehne, N., Grossmann, N., Jung, M., Namgaladze, D., Schmid, T., von Knethen, A., & Weigert, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4785 · Cited by 377
“A cGMP increase in macrophages protects against NO-, ONOO - -, or oxLDL-induced toxicity (112), attenuates proinflammatory cytokine production in LPS-stimulated macrophages (147), reduces high-fat-evoked proinflammatory cytokine production as well as the recruitment of macrophages into adipose tissue (103), and limits…”
BackgroundRole of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease
Hammoutene, A., & Rautou, P.-E. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.012 · Cited by 364
Nitric oxide in liver diseases
Iwakiri, Y., & Kim, M. Y. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.05.001 · Cited by 300
“NO keeps hepatic stellate cells (HSCs) [63, 64] and Kupffer cells quiescent [73].”
BackgroundMacrophage functional diversity in NAFLD — more than inflammation
Barreby, E., Chen, P., & Aouadi, M. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00675-6 · Cited by 247
Metadata
- Authors
- Tateya, S., Rizzo, N. O., Handa, P., Cheng, A. M., Morgan-Stevenson, V., Daum, G., Clowes, A. W., Morton, G. J., Schwartz, M. W., & Kim, F.
- Affiliations
- University of Washington (US)
- Department of Medicine, University of Washington, Seattle, Washington
- Corresponding author
- Kim, Francis
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-10-17
- Volume
- 60
- Issue
- 11
- Pages
- 2792-2801
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3198085
- OpenAlex
- W2152816919
- Cited by
- 138
- References
- 35
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 14 · 2023: 14 · 2022: 7 · 2021: 9 · 2020: 16 · 2019: 9 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 11 · 2014: 7 · 2013: 10 · 2012: 3
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Manpei Suzuki Diabetes Foundation
- National Institutes of Health (5r01dk073878-05)
- National Heart, Lung, and Blood Institute (HL-52459, R01HL052459, R37HL052459)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-083042, DK052989, R01DK052989, R01-DK-073878, DK-073878, R01DK090320, R01DK083042)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- endothelial nitric oxide, Kupffer cell activation, hepatic insulin resistance, high-fat diet, cGMP signaling, VASP, nitric oxide synthase, phosphodiesterase-5 inhibition, liver inflammation, obesity
- MeSH terms
- Vasodilator-Stimulated Phosphoprotein, Animals, Cells, Cultured, Dietary Fats, Gene Expression Regulation, Cyclic GMP, Hepatitis, Insulin Resistance, Kupffer Cells, Liver, Male, Mice, Inbred C57BL, Microfilament Proteins, Nitric Oxide, Obesity, Phosphoproteins, Signal Transduction, Cell Adhesion Molecules, Cytokines, Mice, Knockout, Endothelial Cells, Mice, Nitric Oxide Synthase Type III, Phosphodiesterase 5 Inhibitors, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.